Table 1 Patient background and oncological factors
Auto (N = 99) | Manual (N = 139) | p-value† | ||
|---|---|---|---|---|
Gender (Male, %) | 66 (66.7) | 91 (65.5) | 0.96 | |
Age (year)* | 64.9 ± 11.0 | 65.5 ± 11.3 | 0.87 | |
BMI (kg/m2)* | 23.6 ± 3.55 | 23.0 ± 4.38 | 0.24 | |
ASA-PS (%) | 1 | 27 (27.3) | 46 (33.1) | 0.62 |
2 | 67 (67.7) | 88 (63.3) | ||
3 | 5 (5.1) | 5 (3.6) | ||
Diabetes (%) | 22 (22.2) | 23 (16.5) | 0.35 | |
PNI* | 50.5 ± 5.5 | 51.6 ± 5.2 | 0.10 | |
Histology (%) | Differentiated AC | 92 (92.9) | 125 (89.9) | 0.71 |
Undifferentiated AC | 2 (2.0) | 8 (5.8) | ||
NET | 4 (4.0) | 3 (2.2) | ||
Unknown | 1 (1.0) | 3 (2.2) | ||
tumor size (mm)* | 36.6 ± 19.8 | 38.0 ± 19.9 | 0.54 | |
cT factor (%) | 1 | 24 (24.2) | 31 (22.6) | 0.98 |
2 | 18 (18.2) | 21 (15.1) | ||
3 | 42 (42.4) | 62 (44.6) | ||
4 | 15 (15.2) | 23 (16.5) | ||
cN factor (%) | 0 | 54 (54.5) | 85 (61.2) | 0.30 |
1 | 25 (25.3) | 40 (28.8) | ||
2 | 12 (12.1) | 10 (7.2) | ||
3 | 8 (8.1) | 4 (2.9) | ||
cM factor (%) | 0 | 86 (86.9) | 129 (92.8) | 0.19 |
1 | 13 (13.1) | 10 (7.2) | ||
Preoperative treatment (%) | NAC | 13 (5.5) | 2 (0.8) | 0.002 |
CRT | 2 (0.8) | 2 (0.8) | ||
NAC + CRT | 1 (0.4) | 1 (0.4) | ||